REPORTS

Global Sarcopenia Treatment Market Size study, by Type (Presarcopenia, Sarcopenia, Severe Sarcopenia), Application (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Forecasts 2018-2025

Publishing Date : 15 May 2019 Report Code : Bizwit_1624 Pages : 200 Category : Healthcare and Pharma
Description

Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2018-2025. Reduction of muscle mass considering Sarcopenia leads to loss in muscle function aligned with high changes of functional impairment, mortality and disability in the adult population. Furthermore, malnutrition is one of the emerging causes for early age sarcopenia specially in developing regions. Also changing lifestyle and physical inactivity has led to early age sarcopenia. Increasing prevalence and lack of permanent cure has led to several research and development across the disease. Further changing lifestyles has increased the impact of the disease among the adults in their early 30s. Several initiatives have been taken against the diseases. One such initiative is Canada Sarcopenia Foundation, which is dedicated to preventing and reverse the course of metabolic disease and sarcopenia. Increasing prevalence of sarcopenia across the adults at early age and the rising awareness levels of the consumers is anticipated to drive the growth in pre-sarcopenia market over the forecast period. On the basis of type the Global Sarcopenia market is segmented into Pre-Sarcopenia, Sarcopenia, Severe Sarcopenia. Currently, the market is dominated by sarcopenia market with a majority revenue share of 43.55% in 2017. Sarcopenia is getting very prevalent across the age group of 50-80 years. Severe sarcopenia is more prevalent across people of age group above 80 years. Severe sarcopenia affects both physical performance and strength which includes loss of muscle mass. Knowledge about sarcopenia has increased during the past decade. Various epidemiological and pathophysiological aspects are better understood today than few years ago. Researchers have found that muscle pathology can cause adverse health effect and it is evident with various studies that this adverse consequence are treatable, and the effects can be delayed through certain treatment strategies. The advancement of sarcopenia treatment such as Ursolic acid is a pentaciclyc triterpenoid found in apples. This acid has the potential to reduce muscle weakness and atrophy associated aging. Ursolic acid stimulate an increase in muscle by repressing atrophy-associated skeletal muscle gene expression. These is the major factor that spur the growth of investment for drug and supplement development in Sarcopenia treatment market. The rapid increasing investment for drug and supplement development changes the nature of pricing and competition in the market are also become a reason to enhance the market growth over the coming years. The regional analysis of global sarcopenia treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to surging prevalence of cancer and chronic diseases. Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2018-2025 due to escalating prevalence of geriatric population and surging incidences of diabetes. Market player included in this report are: Abbott Laboratories Pfizer Inc Novartis AG Glaxosmithkline Plc Nestle SA Bayer AG Sanofi SA Amway The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Type: Presarcopenia Sarcopenia Severe Sarcopenia By Application: Hospitals Clinics Ambulatory Surgical Centers By Regions: North America U.S. Canada Europe UK Germany Asia Pacific China India Japan Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2015, 2016 Base year - 2017 Forecast period - 2018 to 2025 Target Audience of the Global Sarcopenia Treatment Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers

Table of Figures

List of Tables TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF SARCOPENIA TREATMENT MARKET TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF SARCOPENIA TREATMENT MARKET TABLE 3. SARCOPENIA TREATMENT MARKET, REPORT SCOPE TABLE 4. YEARS CONSIDERED FOR THE STUDY TABLE 5. EXCHANGE RATES CONSIDERED TABLE 6. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION) TABLE 7. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION) TABLE 8. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION) TABLE 9. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 10. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 11. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 12. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 13. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 14. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 15. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 16. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 17. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 18. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 19. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 20. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 21. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 22. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 23. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 24. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 25. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 26. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 27. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 28. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 29. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 30. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 31. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 32. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 33. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 34. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 35. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 36. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 37. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 38. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 39. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 40. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 41. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 42. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 43. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 44. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 45. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 46. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 47. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 48. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 49. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 50. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 51. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 52. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 53. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 54. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 55. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 56. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 57. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 58. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 59. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 60. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 61. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 62. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 63. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 64. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 65. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 66. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 67. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 68. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 69. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 70. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 71. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 72. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 73. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 74. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 75. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 76. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 77. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 78. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 79. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 80. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 81. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 82. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 83. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 84. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 85. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 86. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 87. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 88. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 89. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 90. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 91. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 92. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 93. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 94. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 95. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 96. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 97. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 98. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 99. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 100. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 101. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 102. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 103. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 104. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 105. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION) TABLE 106. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 107. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 108. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) TABLE 109. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION) ?